FDA
approval
· 2012-07-09
FDA Approved: OXYCONTIN — Supplemental Application (Purdue Pharma LP)
Summary
The FDA approved a supplemental application for OxyContin (oxycodone hydrochloride) submitted by Purdue Pharma LP.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for OXYCONTIN (OXYCODONE HYDROCHLORIDE)